Navigation Links
Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
Date:12/4/2007

CD19 and MDX-1342

CD19 is a B-cell specific membrane protein that is broadly expressed during B-cell development, from the pro-B-cell to the early plasma cell stage.

Clinical studies have demonstrated that depleting monoclonal antibodies directed against CD20, another B-cell specific membrane protein that has a more restricted expression pattern than CD19 during B-cell development, are effective in treating rheumatoid arthritis and various B-cell malignancies, and show promise in treating other inflammatory diseases such as systemic lupus erythematosis and multiple sclerosis.

MDX-1342 is a fully human antibody that binds selectively to CD19 expressed on B-cells (without targeting stem cells or fully differentiated plasma cells, which lack CD19 expression) and induces the depletion and elimination of CD19-positive B-cells.

About Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia (CLL) is a cancer that affects B-cell lymphocytes, an important component of the immune system that helps the body fight infection or cancer. The American Cancer Society estimates that in 2007, approximately 15,340 new cases of chronic lymphocytic leukemia will occur in the United States, and approximately 4,500 people will die of the disease in 2007.

About Rheumatoid Arthritis

According to the American College of Rheumatology, more than two million Americans suffer from rheumatoid arthritis (RA), a chronic autoimmune disease that develops when certain cells of the immune system inappropriately attack healthy joint tissue, thereby causing swelling, inflammation and damage of joints, as well as systemic inflammation and damage of other tissues.

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectio
'/>"/>

SOURCE Medarex, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 Harwood Feffer LLP ... board of directors of PDL BioPharma, Inc. ("PDL" or ... the board has breached its fiduciary duties to shareholders ... September 16, 2014, the Company disclosed: "On September 11, ... accounting firm, Ernst & Young LLP ("EY"), that it ...
(Date:9/19/2014)... 19, 2014 "Copay coupons," a ... of brand drugs among patients with prescription drug coverage, may ... a new report  from the Department of ... General (OIG). Federal anti-kickback laws prohibit suppliers from ... subsidized by the federal government. ...
(Date:9/19/2014)... Sept. 19, 2014 Today, iHealth Lab Inc. announced ... Ventures, Ltd. for its first institutional round of funding. ... iHealth,s global reach, accelerate growth and innovation, and invest ... the investment, Xiaomi Ventures will join iHealth,s board of ... infrastructure and ecommerce. "We are very pleased ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2iHealth Raises $25 Million to Fuel Growth and Global Market Share 2
... , , GREENSBORO, N.C., Dec. 23 ... four users who allege kidney damage due to the use ... in preparation for a colonoscopy. (Holshouser et al v. ... are against two Morrisville, N.C., pharmaceutical companies, Salix Pharmaceuticals, Ltd., ...
... , , Accelerated approval ... Dec. 23 The U.S. Food and Drug Administration today ... ages 65 years and older to prevent disease caused by ... http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , People in this age group ...
Cached Medicine Technology:Suits Commenced Against Maker of Prescription Cleansing Drug 2FDA Approves a High Dose Seasonal Influenza Vaccine Specifically Intended for People Ages 65 and Older 2FDA Approves a High Dose Seasonal Influenza Vaccine Specifically Intended for People Ages 65 and Older 3
(Date:9/21/2014)... Huntington, New York (PRWEB) September 21, 2014 ... release of their Risk Management Portal designed for ... applications with the intent to support effective risk ... is scheduled to go live coinciding with Waldorf’s ... September 21-24, 2014. , These applications were developed ...
(Date:9/21/2014)... PA (PRWEB) September 21, 2014 "I ... boost without having to consume sugary, foul-tasting energy drinks," ... did not always just want to drink plain, old ... alternative energy booster." , He developed ENERG CHEWING GUM ... assist with weight loss. The formula contains nutritious vitamins, ...
(Date:9/21/2014)... cancer cells metastasize? Think of Sparta. , Ancient Greek ... them for the demands of battle on distant fields. ... according to a new study revealing previously unknown differences ... original tumor site, and those that travel to other ... to metastasize is the primary cause of cancer-related death, ...
(Date:9/21/2014)... September 21, 2014 "I want to ... and back but haven’t the money for chiropractors," said ... to have such a product for myself." , The ... to stretch the thigh muscles and align the spine ... as relieves discomfort of pinched nerves. Compact and easy ...
(Date:9/21/2014)... NY (PRWEB) September 21, 2014 ... develops, implements and supports electronic medical records (EMR) ... benefited from federal healthcare legislation during the past ... do so during the five years to 2019. ... Clinical Health Act established Medicare and Medicaid incentives ...
Breaking Medicine News(10 mins):Health News:Waldorf Risk Solutions Releases New Risk Management Portal 2Health News:Cancer cells adapt energy needs to spread illness to other organs 2Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 4
... in Mumbai suffers from backache, caused mainly by the poor ... out by Health India, a New Delhi-based non-profit group, the ... Delhi and 77 percent in Mumbai who use public transport ... ,"Bad roads, overcrowded public transport systems, poor quality of ...
... On the eve of the World AIDS Day (Dec 1), ... to 20,000 HIV infected children, Health Minister Anbumani Ramadoss said ... launching a scheme to provide free ARV treatment for children ... for the paediatric drugs and three to four pharmaceutical companies ...
... of Secondary Education (CBSE) has taken following measures to ... a joyful //experience:- ,(i) Abolition of homework for ... ,(ii) Interesting and meaningful alternative activities to replace the ... ,(iii) Continuous and Comprehensive Evaluation from class ...
... device's track record in the United Kingdom concluded that ... the technology's use at least// for now. The review ... Assessment, the international journal series of the Health Technology ... Research in the United Kingdom. ,An implantable ...
... The Minister of Tourism and Culture Smt. Ambika Soni ... promoting India as a Global Health Care Destination. ... foreign tourist to the country Ministry of Tourism in ... the following measures to promote Medial Tourism: ,i) ...
... a heart attack indicates future heart problems, according to ... edition of the// Journal of the American College of ... of depression after having a heart attack are at ... to undergo new depression-related screening protocols and treatment strategies. ...
Cached Medicine News:Health News:Public Transport Causing Backaches in Delhi, Mumbai 2Health News:Free HIV Treatment to Be Launched for Children 2Health News:Review Urges Restricted Use Of Devices To Keep Heart Patients Alive 2Health News:Review Urges Restricted Use Of Devices To Keep Heart Patients Alive 3Health News:Depression After Heart Attack Means More Heart Problems 2Health News:Depression After Heart Attack Means More Heart Problems 3
2.5% Soytone, 4.8% Yeast Extract, 0.025% Magnesium Sulfate, 130mM Calcium Chloride....
12% Tryptone, 24% Yeast Extract, 4.0% Glycerol. Supplied with 1 liter of 10x phosphate buffer (0190-1L)....
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride, 0.5% Yeast Extract, 1.0% bacto casamino acids, 0.2% Mag. Sulfate....
S.O.C. Medium...
Medicine Products: